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ABSTRACT
Context: Patients with chronic obstructive pulmonary disease (COPD) have a high symptom
burden and reduced quality of life. There is an increasing attention on palliation for patients with
COPD. Recognition of symptoms is a prerequisite for palliation.
Objectives: We aim to investigate the extent to which symptoms in patients with COPD are
recognized in the documentation of the health professionals, indicated in ‘Doctors Symptom
Recognition Rate’ (DSR), ‘Nurses Symptom Recognition Rate’ (NSR) or ‘Doctors and/or Nurses
Symptom Recognition rates ’(DNSR) as a team, respectively.
Methods: Patients with COPD (n = 40) admitted in two respiratory units, responded within 48 h
on two symptom-screening-tools that access quality of life; COPD assessment test (CAT) used for
the treatment of COPD and EORTC-QLQ-C15-PAL used for palliation in patients with cancer.
Patient-described symptomatology was compared to the symptoms as recognized in the doc-
umentation of doctors and/or nurses.
Results: There was a significant discrepancy between the symptomatology indicated by patients
with COPD on CAT and EORTC-QLQ-C15-PAL, and the degree by which it was recognized in the
medical records indicated in DSR or NSR. In 30 out of 44 items DSR or NSR were < 70%. There was
a significant difference between DNSR versus DSR or NSR, respectively, in 19 out of 22 items.
Conclusion: A team-based symptom recognition DNSR is superior when compared to DSR or NSR.
Team-based systematic screening is suggested as a pathway to increase symptom recognition
in patients with COPD. Increased rates of symptom recognition may improve symptom alleviation
and thus palliation.
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Introduction
Chronic obstructive pulmonary disease (COPD) is highly
prevalent and is worldwide associated with high morbid-
ity and mortality [1–4]. A global estimate from 2016
indicates that about 65 million people live with COPD
an amount that is expected to increase as the population
ages [5,6]. More than 3 million people died of COPD in
2015 which amounts to approximately 5% of global
deaths that year [5]. Currently COPD is the fourth lead-
ing cause of death [7] and theWorld Health Organization
(WHO) projects it to be the third leading source of
mortality by 2020 [5].
Patients with COPD often experience long disease tra-
jectories characterized by a substantial burden of symp-
toms, impaired functional status and thereby reduced
quality of life [8]. The course of disease is unpredictable
due to exacerbations, a decline in respiratory condition in
addition to normal day-to-day changes, that are associated
with an increased risk of dying [5,6,9–13]. Literature indi-
cates that patients with COPD lives with a symptom bur-
den comparable to patients with lung cancer in the
advanced stage of the disease [14,15].
Palliative care aims to alleviate symptoms and thus
increase quality of life for patients and their families
[6,16]. Patients with advanced COPD benefit equally
from palliative care compared to patients with malig-
nant diseases [17]. Despite of this, palliative care in a
specialized unit is offered to patients with COPD to a
lesser extend than to patients with a malignant disease
[15,18]. Few existing studies evaluate the effect of
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palliative care outside a specialized unit directed at
patients with COPD [12,15,19–22].
Currently, there is a growing attention upon palliative
care to patients with life-threatening non-malignant dis-
eases as COPD. Palliation has historically been linked to
the symptomatology experienced by patients with cancer.
It is presumed within oncology that doctors’ and nurses’
symptom recognition is a fundament for the palliative
care offered, based on the assumption that if a symptom is
not recognized and documented by health professionals,
it is unlikely that it will be treated. Studies conducted
within a population of patients with cancer shows a dis-
crepancy between symptoms reported by patients and the
extent to which they are acknowledged by health profes-
sionals [23,24]. This discrepancy reduces chances of
symptom alleviation and subsequent increased quality
of life [23–25]. Systematic screening for symptoms has
been suggested as a way to ensure palliative care in
specialized units [23–26,27].
The first step towards ensuring palliative care to
patients with life-threatening non-malignant disease,
must be to make sure that their symptoms are recog-
nized and documented by health professionals in the
medical records.
To the best of our knowledge a validated question-
naire or screening-tool reflecting the palliative symp-
toms of patients with COPD does not exist, nor do
studies elucidating if symptoms are documented.
The aim of this study was to investigate the degree
to which symptoms described by admitted patients
with COPD through Patient Reported Outcome
(PRO) were recognized and documented by health
professionals.
Since palliative care aims to alleviating symptoms,
the attention of this study was put on symptoms with
high intensity and thus a potential for alleviation.
In line with previous studies we wish to estimate
‘Doctor’s Symptom Recognition percentage’ (DSR)
[24] and ‘Nurse’s Symptom Recognition percentage’
(NSR) [23], i.e., – the extend to which symptoms
with high intensity experienced by admitted patients
with COPD and described by either COPD assessment
test (CAT) [28] or European Organisation for Research
and Treatment for Cancer’s questionnaire reflecting
palliative symptoms (EORTC-QLQ-C15-PAL) [29] are
recognized by health professionals.
Methods
A prospective survey within a cross-sectional setting
was conducted obtaining data from patients admitted
with COPD in respiratory units in two different hospi-
tals located in the capital region of Denmark.
According to The Ethics Committee (www.nvk.dk) in
Denmark, the Biomedical Research Ethics Committee
System Act does not apply to survey and qualitative
studies in general nor the present study. Participants
are referred to by pseudonyms and written informed
consents were obtained from all patients before
participation.
Patient selection
Patients were included consecutively through cluster-sam-
pling from 13 March 2017 to 11 April 2017 from two
respiratory units located in different parts of
Copenhagen. Inclusion every second day from each hospi-
tal if patients had been admitted less than 48 h until n = 40.
Eligible criteria of inclusion were:
-Diagnosis of COPD according to Global initiative
for chronic Obstructive Lung Disease (GOLD)[6] cri-
teria, age ≥ 18 years, Danish speaking and able to give
an informed consent according to Danish law.
Exclusion criteria were:
-If interviewer assessed patients to weak to partici-
pate in interview, had cognitive deficits and/or a cancer
diagnosis.
In total 40 patients were included, n = 4were estimated
to weak to participate, n = 3 were treated with acute non-
invasive-ventilation increasing the risk of cognitive defi-
cits and n = 3 declined participation (Figure 1).
Measures
Demographic and disease-related data were obtained
from medical records. Patients reported symptoms by
CAT [28] and EORTC-QLQ-C15-PAL [29]. Patient
reported outcomes (PRO-data) were all collected
within first 48 h of admission.
COPD assessment test (CAT)
CAT [28] was designed to reflect the impact of COPD on
patients’ health status [30]. CAT was developed based on a
population containing all degrees of COPD (n=1503) [30].
Through item response theory (IRT) eight items were
identified each covering a symptom. Intensity of symptoms
are measured on a rating-scale ranging from 0 to 5 [31]
giving CAT a max score of 40. A change of two units is
accepted as minimum clinically significant change [32].
Scorings-algorithms are developed transforming
raw-data from an expression of symptom intensity
into effects on patients health [33].
According to GOLD classification a CAT-score> 10
units is interpreted as symptomatic COPD [6]. CAT-
scores are assessed when patients are categorized based
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on symptoms and exacerbations in GOLD classifica-
tion (A-D).
EORTC-QLQ-C15-PAL
EORTC-QLQ-C30 [34] resamples HRQoL in patients
with advanced, incurable and symptomatic cancer with
a median life expectancy of a few months [35].
EORTC-QLQ-C30 is extensively validated for patients
with cancer [36–38] and the use of it is supported by
standardized procedures for scores [39] and evidence
for interpretation of scores [39,40]. EORTC-QLQ-C15-
PAL[29] has become a shortened version of EORTC-
QLQ-C30 through IRT preserving item-properties and
procedures for scores [35,41–43].
EORTC-QLQ-C15-PAL consists of 15 items of
which 14 items are measured on a rating-scale ran-
ging from 1 to 4 equivalent to: 1 = ‘not a problem’,
2 = ‘ a little’, 3 = ‘quite a bit’ and 4 = ‘very much’.
Item 15 is rating quality of life on a scale ranging
from 1 to 7, 7 being highest quality of life.
Functional scales are represented by item 1–3, symp-
tom scales by item 4–14 while quality of life is
represented by item 15. Raw-data rated from 1 to 4
can be transformed into a Likert-scale ranging from
0 to 100 (Figure 2)
Obtaining pro-data
With an awareness that symptomatology changes
according to patients being in a stable phase at home
or in a acute phase during the first days of hospitaliza-
tion, all patients were instructed to answer CAT and
EORTC-QLQ-C15-PAL according to current symp-
toms and symptoms within the last seven days.
To minimize missing data and to increase data
completeness all PRO-data was obtained through inter-
views and administrated by a health professional. To
ensure consistency all interviews were conducted by
first author.
Extracting data from medical records
To identify if symptoms reported by patients were recog-
nized by health professionals we constructed a checklist
containing 23 items based on the two questionnaires: 8
scales from CAT and 15 from EORTC-QLQ-C15-PAL.
N=50
all inclusion 
criteria were 
met
N=40
 Included
Period march-june 2017
N=3
Excluded due to  
Non-invasive-ventilation (NIV)
N=3
Did not wish to participate
N=4
Excluded because they were  
estimated to weak to participate
13/3-17
Inclusion. 
Obtaining data
Review of  
medical records
11/4-17
12/5-17
Juni 2017
N=47
N=43
Figure 1. Flow-chart of inclusion and exclusion.
0
Not a problem (1)
33,3
A little (2)
66,7
Quite a bit (3)
100
Very much (4)
Figure 2. Transformation og raw-data into a Likert-scale ranging from 0–100.
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Symptom recognition of health professionals was regis-
tered for doctors andnurses, respectively, andwas reviewed
qualitatively. Braden-score and ‘functionality and activity’-
screenings were both a part of daily documentation for the
nurses in both units and were obtained as recognition of
functionality scales item 1–3 on EORTC-QLQ-C15-PAL
and item 5 ‘activities home’ on CAT.
To optimize objectivity and minimize bias review of
documentation was blinded to PRO-data. If a symptom
was recognized, date and citation were noted on the
checklist to secure validity through transparency.
Data validation
To validate the data an independent reviewer con-
ducted same procedure, as described above, in a ran-
dom sample of n = 14(35%) of the 40 included medical
records and 87.4% of consensus was found.
A rate of 87.4% of consensus in data registration is
accepted as high validity of data.
Statistics
Categorization
DSR and NSR will be calculated as the percentage of
symptoms described by patients with intensities above
the cut-off recognized by health professionals in the
medical records.
As an alternative to single recognition by DSR or
NSR is a team-based recognition defined as ‘Doctors
and/or Nurses Symptom Recognition rates’ (DNSR).
A recognition rate > 70% is accepted as a threshold
providing a minimum basis for symptom alleviation in
relation to palliative care. For this purpose it is neces-
sary to define which responses describe a symptom
with potential for alleviation, i.e., a cut-off-value for
symptoms according to CAT and EORTC-QLQ-C15-
PAL, respectively
Cut-off-values for symptoms rated on CAT
A score of two units in CAT as a cut-off-value for a
symptom corresponds with the minimal clinical difference
of two units described by jones et al [31]. Subsequently, this
study accepts a score of two units in CAT as a symptom
and score above two units as high intensity symptoms.
Cut-off-values for symptoms rated on EORTC-QLQ-
C15-PAL
In alliance with previous studies [23,24], this study also
accepts a symptom intensity of 2 in EORTC-QLQ-C15-
PAL as a threshold and proclaims it our cut-off-value. All
intensities> 2 will be regarded as high intensity.
Equivalence and correspondence between CAT and
EORTC-QLQ-C15-PAL
Previous studies have converted CAT and EORTC-
QLQ-C30 into scales ranging from 0 to 100 [23,24,32].
If we divide 100 with 6 categories on CAT’s Likert-
scale (0, 1, 2, 3, 4 and 5), then each category equals to
16.67%. If we accept a cut-off-value of 2 on the Likert-
scale then it corresponds to 3 units on the Likert-scale
(0, 1, 2) meaning; 3 × 16.67% = 50% .
If we convert the Likert-scales of EORTC-QLQ-
C15-PAL into 0–100% and divide it by the four cate-
gories (1, 2, 3 and 4), we find that each category
equals to 25%. If we accept a cut-off-value of 2 on
the Likert-scale then it corresponds to 2 ×
25% = 50%.
On this basis we argue that a symptom intensity of 2 on
CAT is equivalent to and corresponds with a symptom
intensity of 2 on EORTC-QLQ-C15-PAL. From this
point and onwards interest will be on data describing
symptoms with intensities above 2 i.e., (3, 4 and5) and
thus potential for alleviation and hereby palliative care.
Patient’s scores on CAT and EORTC-QLQ-C15-
PAL were cross-tabulated against the dichotomous out-
come of whether or not a symptom was recognized in
the medical records of the same patient by doctors or
nurses, respectively. Chi-square-test calculated p-values
to describe if symptom recognition was significantly
different doctors versus nurses, and to describe if a
team-based recognition was significantly different to
doctors’ or nurses’ recognition, respectively. p < 0.05 I
accepted as significant.
Global QOL on EORTC-QLQ-C15-PAL was not
interpreted as a symptom and was excluded from
cross-tabulation. Global QOL is shown as a mean
with a range (min;max) and SD.
Results
The demographic data of the population are shown in
Table 1.
All included patients n = 40 answered all items on
both questionnaires.
n = 40 Patients described Global QOL on a scale
with a range from 1 to 7 giving a mean = 3, 13(1;7) and
SD = 1,522.
In 1 out of 40 reviews, QOL was recognized by
doctors and nurses in the medical records correspond-
ing to DSR 2.5% and NSR 2.5%.
Symptoms with high intensity described by patients
admitted with COPD.
Table 2 shows the number of patients who experi-
enced high symptom intensity corresponding to a raw-
score> 2.
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CAT-score’s converted to percentage’s (Np> 2 CAT/N)
× 100 shows: ‘Cough’ 65%, ‘Phlegm’ 55%, ‘Chest feels tight’
25%, ‘Breathless’ 90%, ‘Activities home’ 82.5%, ‘Confident’
30%, ‘Sleep’ 47.5% and ‘Energy’ 90%.
EORTC-QLQ-C15-PAL-scores converted to percen-
tages (Np> 2 EORTC-QLQ-C15-PAL/N)x 100 shows:
‘Short walk outside’ 67%, ‘bed-chair’ 60%, ‘Help-activ-
ities of daily living’ 17%, ‘short of breath’ 75%, ‘Pain’
27%, ‘Trouble sleeping’ 42.5%, ‘Felt weak’ 85%,
‘Appetite’ 47.5%, ‘Nauseated’ 12.5%, ‘Constipated’
17.5%, ‘Tired’ 82.5%, ‘Pain daily activities’ 17.5%,
‘Tense’ 42.5% and ‘Depressed’ 17.5%.
Analysis reflected in table 3 shows that 14 out of 44 items
reflecting symptoms with high intensity potential for alle-
viation were recognized in the medical records by
rates> 70%: DSR PAL ‘help activities of daily living’ 71%,
DSR PAL ‘Pain’ 73%, DSR PAL ‘Short of breath’ 97%, DSR
CAT ‘Cough’ 85%, DSR CAT ‘Breathless’ 100%, NSR PAL
‘Trouble sleeping’82%, NSR PAL ‘Constipated’ 86%, NSR
CAT ‘Sleep’ 89%, NSR PAL ‘Depressed’ 71%, NSR PAL
‘Short walk outside’ 93%, NSR PAL ‘Bed/chair’ 92%, NSR
PAL ‘help activities of daily living’ 100%, NSR PAL
‘Appetite’ 95% and NSR CAT ‘ Activities at home’ 94%.
Main symptoms of patients admitted with COPD
were dyspnoea, exemplified by CAT ”breathless” 90%
and PAL ‘short of breath’ 75%.
Symptoms of high intensity, with a preva-
lence> 70% described by admitted patients with
COPD apart from their main symptom dyspnoea
were: CAT ‘Activities at home’ 82%, CAT ‘energy’
90%, PAL ‘Felt weak’ 85% and PAL ‘Tiered’ 82.5%.
Just 1 of these symptoms was recognized with a
rate> 70% (NSR CAT ‘Activities home’ 94%) the
rest were recognized by rates ranging between 18%
and 45% (Table 4).
Table 4 shows that in 9 out of 22 items, DSR were
significantly lower (p < 0.05) when compared to DNSR
Table 1. Demographic data and FEV 1, FVC and FEV1/FVC.
Demographic data (n = 40)
Sex (female/male) 18/22
Age (years) 77 (54; 92)
Mean Range
FEV1(n = 39) (missing data = 1) 42 (12; 77)
FVC (n = 30) (missing data = 10) 59 (23; 97)
FEV1/FVC (n = 28) (missing data 12) 51 (30; 79)
Age and range are shown as a Mean (min:max). FEV1 and FVC are shown as % of predicted. FEV1/FVC is shown as %.
Table 2. Number of patients who experienced high symptom intensity corresponding to a raw-score> 2.
3 4 5 3 + 4 + 5
Np (%) Np (%) Np (%) Np (%)
CAT_cough 30% (12) 20% (8) 15% (6) 65% (26)
CAT_phlegm 27.5% (11) 17.5% (7) 10% (4) 55% (22)
CAT_chest feel tight 10% (4) 7.5% (3) 7.5% (3) 25% (10)
CAT_breathless 17.5% (7) 12.5% (5) 60% (24) 90% (36)
CAT_activities home 27.5% (11) 22.5% (9) 32.5% (13) 82.5% (33)
CAT_confident 7.5% (3) 12.5% (5) 10% (4) 30% (12)
CAT_sleep 12.5% (5) 20% (8) 15% (6) 47.5% (19)
CAT_energy 30% (12) 22.5% (9) 37.5% (15) 90% (36)
PAL_short walk outside 22.5% (9) 45% (18) NA 67% (27)
PAL_-bed-chair 25% (10) 35% (14) NA 60% (24)
PAL_help-activities of daily living 5% (2) 12.5% (5) NA 17.5% (7)
PAL-short of breath 15% (6) 60% (24) NA 75% (30)
PAL_pain 20% (8) 7.5% (3) NA 27.5% (11)
PAL_trouble sleeping 22.5% (9) 20% (8) NA 42.5% (17)
PAL_felt weak 30% (12) 55% (22) NA 85% (34)
PAL_appetite 15% (6) 32.5% (13) NA 47.5% (19)
PAL_nauseated 5% (2) 7.5% (3) NA 12.5% (5)
PAL_constipated 12.5% (5) 5% (2) NA 17.5% (7)
PAL_tired 27.5% (11) 55% (22) NA 82.5% (33)
PAL_pain-daily-acttivities 12.5% (5) 5% (2) NA 17.5% (7)
PAL_tense 32.5% (13) 10% (4) NA 42.5% (17)
PAL_depressed 12.5% (5) 5% (2) NA 17.5% (7)
Top-row represents symptom intensity (3–5) corresponding with Likert-scales on CAT and EORTC-QLQ-C15-PAL. Last column accumulates symptom intensities > 2.
First column from the left describes questionnaire and item.
Np% the percentage of patients who experience the symptom described by the item, with the intensity the number above the column shows followed by the
actual number of patients who experience the symptom described by the item.
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(yes or yes). In 11 out of 22 items, NSR were signifi-
cantly lower (p < 0.05) when compared to DNSR (yes
or yes). In total there was a significant difference
between DNSR versus DSR or NSR, respectively, in
19 items. In three items there was no significant dif-
ference between DNSR versus DSR or NSR, respec-
tively. The three items with no significant difference
were: Cat-confident, PAL-help activities of daily living
Table 3. Doctors’ symptom recognition (DSR) and nurses’ symptom recognition (NSR) shown as %.
3 4 5
Np (%) DSR NSR Np (%) DSR NSR Np (%) DSR NSR
CAT_cough 30% (12) 67% (8) 8% (1) 20% (8) 100% (8) 38% (3) 15% (6) 100% (6) 17% (1)
CAT_phlegm 27.5% (11) 55% (6) 0% (NA) 17.5% (7) 71% (5) 14% (1) 10% (4) 75% (3) 25% (1)
CAT_chest feel tight 10% (4) 50% (2) 0% (NA) 7.5% (3) 0% (NA) 0% (NA) 7.5% (3) 100% (3) 33% (1)
CAT_breathless 17.5% (7) 100% (7) 43% (3) 12.5% (5) 100% (5) 80% (4) 60% (24) 100% (24) 33% (8)
CAT_activities home 27.5% (11) 36% (4) 91% (10) 22.5% (9) 44% (4) 89% (8) 32.5% (13) 54% (7) 100% (13)
CAT_confident 7.5% (3) 0% (NA) 0% (NA) 12.5% (5) 40% (2) 0% (NA) 10% (4) 50% (2) 50% (2)
CAT_sleep 12.5% (5) 60% (3) 100% (5) 20% (8) 38% (3) 75% (6) 15% (6) 17% (1) 100% (6)
CAT_energy 30% (12) 25% (3) 8% (1) 22.5% (9) 44% (4) 11% (1) 37.5% (15) 53% (8) 40% (6)
PAL_short walk outside 22.5% (9) 56% (5) 89% (8) 45% (18) 50% (9) 94% (17) (NA) - -
PAL_-bed-chair 25% (10) 10% (1) 90% (9) 35% (14) 36% (5) 93% (13) (NA) - -
PAL_help-activities of daily living 5% (2) 0% (NA) 100% (2) 12.5% (5) 100% (5) 100% (5) (NA) - -
PAL-short of breath 15% (6) 100% (6) 67% (4) 60% (24) 96% (23) 46% (11) (NA) - -
PAL_pain 20% (8) 63% (5) 38% (3) 7.5% (3) 100% (3) 67% (2) (NA) - -
PAL_trouble sleeping 22.5% (9) 22% (2) 67% (6) 20% (8) 13% (1) 100% (8) (NA) - -
PAL_felt weak 30% (12) 17% (2) 8% (1) 55% (22) 36% (8) 27% (6) (NA) - -
PAL_appetite 15% (6) 0% (NA) 100% (6) 32.5% (13) 46% (6) 92% (12) (NA) - -
PAL_nauseated 5% (2) 0% (NA) 0% (NA) 7.5% (3) 100% (3) 33% (1) (NA) - -
PAL_constipated 12.5% (5) 40% (2) 80% (4) 5% (2) 100% (2) 100% (2) (NA) - -
PAL_tired 27.5% (11) 9% (1) 18% (2) 55% (22) 36% (8) 18% (4) (NA) - -
PAL_pain-daily-acttivities 12.5% (5) 0% (NA) 0% (NA) 5% (2) 0% (NA) 0% (NA) (NA) - -
PAL_tense 32.5% (13) 38% (5) 46% (6) 10% (4) 100% (4) 75% (3) (NA) - -
PAL_depressed 12.5% (5) 20% (1) 60% (3) 5% (2) 0% (NA) 100% (2) (NA) - -
Top-row represents symptom intensity (3–5) corresponding with likert-scales on CAT and EORTC-QLQ-C15-PAL. Last column accumulates symptom intensities> 2.
First column from the left describes questionnaire and item. Np% The percentage of patients who experience the symptom described by the item, with the
intensity the number above the column shows, followed by the actual number of patients. DSR = Doctors symptom recognition calculated as a percentage:
(Number of doctors recognizing the symptoms in the medical records/N) x 100%. NSR = Nurses Symptom Recognition calculated as a percentage: (Number of
nurses recognizing the symptom in the medical records/N) x100%.
Table 4. Recognition rates of symptoms with high intensity documented in the medical records.
3 + 4 + 5
Np (%) DSR NSR
DNSR (yes or
yes)
DNSR (yes or yes) vs
DSR
DNSR (yes or yes) vs
NSR
DSR vs
NSR
CAT_cough 65% (26) 85% (22) 19% (5) 85% (22) 1,0000 < .0001 < .0001
CAT_phlegm 55% (22) 64% (14) 9% (22)2 68% (15) 0,3173 < .0001 < .0001
CAT_chest feel tight 25% (10) 50% (5) 10% (1) 50% (5) 1,0000 0,0001 0,0001
CAT_breathless 90% (36) 100% (36) 42% (15) 100% (36) 1,0000 < .0001 < .0001
CAT_activities home 82.5% (33) 45% (15) 94% (31) 94% (31) < .0001 1,0000 < .0001
CAT_confident 30% (12) 33% (4) 17% (2) 42% (5) 0,3173 0,0833 0,3173
CAT_sleep 47.5% (19) 37% (7) 89% (17) 95% (18) < .0001 0,3173 < .0001
CAT_energy 90% (36) 42% (15) 22% (8) 50% (18) 0,0833 0,0009 0,0325
PAL_short walk outside 67% (27) 52% (14) 93% (25) 96% (26) < .0001 0,3173 < .0001
PAL_-bed-chair 60% (24) 25% (6) 92% (22) 92% (22) < .0001 1,0000 < .0001
PAL_help-activities of daily living 17.5% (7) 71% (5) 100% (7) 100% (7) * * < .0001
PAL-short of breath 75% (30) 97% (29) 50% (15) 97% (29) 1,0000 < .0001 < .0001
PAL_pain 27.5% (11) 73% (8) 45% (5) 73% (8) 0,1573 < .0001 0,0003
PAL_trouble sleeping 42.5% (17) 18% (3) 82% (14) 88% (15) < .0001 0,1573 < .0001
PAL_felt weak 85% (34) 29% (10) 21% (7) 38% (13) 0,0833 0,0027 0,0833
PAL_appetite 47.5% (19) 32% (6) 95% (18) 95% (18) < .0001 1,0000 < .0001
PAL_nauseated 12.5% (5) 60% (3) 20% (1) 60% (3) 0,0833 0,0253 0,4795
PAL_constipated 17.5% (7) 57% (4) 86% (6) 86% (6) < .0001 0,3173 < .0001
PAL_tired 82.5% (33) 27% (9) 18% (6) 33% (11) 0,1573 0,0082 0,0956
PAL_pain-daily-acttivities 17.5% (7) 0% (NA) 0% (NA) 0% (NA) * * *
PAL_tense 42.5% (17) 53% (9) 53% (9) 76% (13) 0,0005 0,0253 0,0896
PAL_depressed 17.5% (7) 14% (1) 71% (5) 86% (6) 0,0002 0,3173 0,0008
Table 4 shows recognition rates of symptoms of high intensity documented in the medical records by doctors DSR, nurses NSR and by ‘Doctors and/or Nurses Symptom
Recognition rates ’ (DNSR) as a team. The team-based recognition is exemplified by DNSR containing the accumulated sum of: DNSR (yes;no/no;yes/yes;yes).
Top-row represents symptom intensity (3–5) corresponding with Likert-scales on CAT and EORTC-QLQ-C15-PAL.. First column from the left describes questionnaire
and item. Np(%) The percentage of patients who experience the symptom described by the item, with the intensity > 2. Last three columns at the right shows
P-values for significance in recognition for DSR versus DNSR, NSR versus DNSR and for DSR versus NSR. p < 0.05 being significant.
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and PAL-pain-daily-activities. There were no signifi-
cant difference between DSR and NSR I 6 out of 22
items, the six items being: Cat-Confident, PAL-Felt
weak, PAL-Nauseated, PAL-Tired, (PAL-Pain daily
activities) and PAL-Tense.
Figure 3 shows that a total of two items CAT ‘Chest
felt tight’ and PAL ‘Pain daily activities’ did not show
significance in DNSR versus DSR or NSR. Nor did they
show improvement in recognition rates DNSR versus
DSR or NSR.
Discussion
Acknowledging symptoms is a prerequisite for allevia-
tion and thus palliative care. The main findings of the
present study is:
● A substantial discrepancy between symptoms of
high intensity described by patients with COPD
on CAT and EORTC-QLQ-C15-PAL during hos-
pitalization and the rates of which, they are recog-
nized by health professionals in the medical
records.
● Highly recognized rates were in five out of seven
symptoms obtained by mandatory screenings.
● Most prevalent symptoms of high intensity can be
described as diffuse weakness.
● Items recognized by a rate< 70% were all symp-
toms with treatments and thus possible alleviation
by palliative care.
● A team-based symptom recognition DNSR is
superior to DSR or NSR.
In the 14 symptoms out of 44 recognized by a rate
> 70%, 7 were recognized by very high rates ranging
between 90% and 100%. From the seven very highly
recognized rates, five were obtained by mandatory
screenings of functionality conducted by the nurses:
NSR PAL ‘Short walk outside’ 93%, NSR PAL ‘Bed/
chair’ 92%, NSR PAL ‘help activities of daily living’
100%, NSR PAL ‘Appetite’ 95% and NSR CAT‘
Activities at home’ 94%.
The remaining two rates of very high recognition
were doctors’ recognition of the main symptom of
patient with COPD being dyspnoea exemplified by:
DSR PAL ‘Short of breath’ 97% and DSR CAT ‘breath-
less’ 100%. The high level of recognition among the
Figure 3. Illustrates how team-based total recognition DNSR is an improvement versus DSR or NSR in 10 out of 22 items: CAT
‘Phlegm’, CAT ‘Confident’, CAT ‘Sleep’, CAT ‘Energy’, CAT ‘ Short walk outside’, PAL ‘Trouble sleeping’, PAL ‘Felt weak’, PAL ‘Tired’,
PAL ‘Tense’ and PAL ‘Depressed’.
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doctors of these main symptoms of COPD is expected
in a specialized respiratory unit, and is much higher
than what was found among doctors (46%) in specia-
lized palliative cading to Strömgren et al [24].
It is striking that these main symptoms of COPD
are not recognized by nurses in respiratory units to
a degree > 70%. One possible explanation may be
that vital values such as saturation, respiratory
quince and supplemental oxygen are documented
by numbers according to algorithms.
One of 14 items recognized by rates> 70% describes
a psychological symptom. This is in concordance with
Strömgren et al. proclaiming that physical symptoms
much more often are recognized when compared to
psychological symptoms [24].
This distribution is concerning as this study was con-
ducted in a population of patients with COPD with litera-
ture giving evidence that the main symptom dyspnoea
affects patient’s cognitive and affective functions including
anxiety and depression [44–46] and that prevalence of
anxiety is 10 times higher among patients with COPD
versus the average population [47,48]. With 42.5% of
included patients claiming to feel tense, corresponding to
a severe intensity; an indication of a significant symptom
that is recognized in literature but not recognized sufficient
in practice is given.
Most patients with COPD indicated that they felt
very limited in all activities at home, felt a reduction in
their energy level and had a feeling of being very weak
and tired. Only the patient’s limitation in activities at
home was recognized to a degree> 70% (NSR 94%).
The described symptomatology could be presented
as diffuse weakness difficult to intervene on. According
to Stömgren et al. medical records often tends to be
action-oriented and focuses on symptoms you can
intervene on[23,24], which might be part of the expla-
nation of the relatively low rates of recognition.
Patients describing the symptom ‘pain daily activities’ of
high intensity were not recognized at all by either doctors
or nurses. Complete lack of recognitionmight be prevented
if patient symptomatology is screened in fixed algorithms.
In 30 out of 44 items DSR or NSR were < 70%.
Items recognized by a rate< 70% were all symptoms
with possible treatments and thus potential to be alle-
viated by palliative care. The bigger the discrepancy the
bigger the risk, those symptoms with potential of alle-
viation, is neither recognized by doctors nor nurses.
Only two items did neither show an improvement in
recognition rates when a team-based recognition was
compared to either DSR or NSR, nor did they show a
significant difference between recognition rates of either
DSR or NSR versus DNSR. Since 19 out of 22 items
were improved in recognition rates if DNSR was
compared to either DSR or NSR, it is explicit that a
team-based recognition is preferable to both DSR and
NSR if total symptom recognition is at aim. A method
to elucidate symptoms could be by mandatory screen-
ings repeated by fixed algorithms and based upon a
team-based intervention to ensure recognition. A proce-
dure could be nurses obtaining PRO-data by relevant
questionnaires and doctors contra-signing them.
Ethical considerations as to what resources patients
were asked to use on questionnaires was relevant, mak-
ing it a priority to access data via short schemes in
recognition of the patients’ often weakened condition.
Despite significant physical barriers, there was great
support amongst patients as well as relatives, who
often stated that they experienced the problem as
meaningful and current, in full compliance with pre-
vious studies within palliation[49,50].
When interpreting symptom intensities and recog-
nition rates of this study in relation to palliative care, it
is necessary to take into account that seven patients
were excluded due to an acute and instable respiratoric
state or because they were evaluated to weak for parti-
cipation, therefore being in an increased risk of dying.
Thus exclusion of these patients might bias our results.
Another point to take into consideration is the fact that
included patients might not reflect the population that
EORTC-QLQ-C15 aims at, being a population with a life
expectancy of only a fewmonths. Our included population
is however in concordance with WHO’s definition of pal-
liation[16] and reflects the with span of the disease trajec-
tory aswell as the acknowledgement that a prediction of life
expectancy in COPD is not reliable [51].
EORTC-QLQ-C30 was shorten into EORTC-QLQ-
C15-PAL by IRT based on a population n = 8242 of
which n = 904 (11%) was characterized as palliative [42].
No evidence of different item function (DIF) was found
between ‘palliative patients’ versus ‘non-palliative patients’
and the ‘general population’ [42]. This might provide a
psychometric argument to use EORTC-QLQ-C15-PAL
on a population with a life expectancy beyond a few
months as presented in this study.
In CAT six out of eight items refers to respiratory
symptoms reducing the questionnaire’s ability to reflect
the multi-morbidity this population is known by.
Limitations
Since CAT and EORTC-QLQ-C15-PAL have been vali-
dated on different populations it is not given that mea-
sures between the two are equivalent making the two
questionnaires able to correspond. Correspondence and
equivalence between CAT and EORTC-QLQ-C15-PAL
are thus arbitrary and should be interpreted as such.
8 C. SANDAU ET AL.
Furthermore EORTC-QLQ-C15-PAL has not been
validated for patients with COPD giving us no basis to
calculate statistical power and therefore a limited abil-
ity to evaluate the data statistically. Our main focus has
been recognition rates and we have no reason to
believe that they would change significantly if more
patients were included which is why a relatively small
sample size n = 40 was accepted for this study as we are
pioneering the cross-field between COPD care and
palliative care.
Interpretation and generalizability of the data
extracted from the medical records may be put to
question as both units used the same documentation-
system (Epic). Since our main results en general reflect
the ones found in earlier studies [23,24] we believe it
advocates for the generalizability of our results.
Conclusion
This study illustrates a symptomatology that reaches
beyond CAT and into EORTC-QLQ-C15-PAL in a
population with COPD showing the most prevalent
symptoms with high intensity in the sample can be
described as diffuse weakness.
To our knowledge our study is the first to put fourth
evidence of a substantial discrepancy between symp-
toms described by patients with COPD and the degree
by which they are recognized by health professionals.
Symptoms with low recognition rates all had potential
treatments and thus options of alleviation if
recognized.
It is shown that a team-based symptom recognition
DNSR is superior when compared to DSR or NSR.
Team-based systematic screening is suggested as a
pathway to increase symptom recognition in patients
with COPD.
Current results, discussion and conclusion reveal
symptoms identified with PRO-data by a simple pro-
cedure that could be the focus of interest in relation to
new studies on palliation for patients with COPD. New
screening-tools able to reveal a wide range of symp-
toms elucidating the multi morbidity and complexity
of patients with COPD could contribute positively to
the development of palliative care for this very
population.
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